August 5, 2019
Thor Equities has launched a platform specializing in life sciences. The launch of Thor Sciences comes on the heels of Thor’s $152-million acquisition of the Center of Excellence (pictured), a 784,000-square-foot campus located in Bridgewater, NJ and anchored by Nestlé Health Science, Ashland and Amneal Pharmaceuticals.
“We have been an early advocate for the sector, having previously acquired assets in Berkeley and Boston, and are now ready to advance our global platform with the appointment of life sciences expert, and new senior vice president, Bill Hunter,” said Thor chairman and CEO Joseph Sitt. “Bringing over 20 years of experience to Thor, Bill played an instrumental role” in acquiring the Center of Excellence.
Hunter, who has executed approximately $4 billion in acquisitions, said he looked forward to creating “a world-class property” at the Bridgewater campus, “and contributing to the acquisition and development of properties throughout the U.S. and beyond.”
For comments, questions or concerns, please contact Paul Bubny